It sounds like science fiction, but European researchers are starting work on building a model of a fully functioning human brain after winning one of the biggest research grants ever awarded – and they hope the device will help them tackle diseases like Alzheimer’s and Parkinson’s.
The EUR 1 billion Human Brain Project (HBP), one of the EU's flagship research projects for the next 10 years, will employ supercomputers to reconstruct a human brain and then use it to control robots and test out drug treatments.
As people live longer, brain diseases like Alzheimer's have become some of society's most pressing problems. The hope is that the HBP will help scientists test and develop treatments because they'll be able to see how they work on the whole brain, not just a part.
Today you have scientists working on a genetic, behavioural or cognitive level, and then you have informaticians, chemists and mathematicians. They all have their own understanding of how the brain functions and is structured.
‘We want to reach a unified understanding of the brain and the simulation on a supercomputer is the tool,’ says Professor Henry Markram, who is coordinating the project from the Ecole Polytechnique Federale de Lausanne, in Switzerland.
Researchers on the HBP, including many of Europe's best neuroscientists, doctors, physicists and mathematicians, will use a progressively scaled-up, multilayered simulation running on a supercomputer. In total, over 80 institutions are involved in this project.
‘The biggest success for me would be if, after 10 years, we have a new model for neuroscience where everyone works together.’
Professor Henry Markram, Ecole Polytechnique Federale de Lausanne, Switzerland.
Prof. Markram's fascination with the brain began with a school assignment in his native South Africa. He was 14, and as he sat in the library reading about depression, he was astonished to discover there might be ‘molecular explanations to mental illness’ that could be treated with drugs.
In HBP, scientists will build a model of the brain that will help them study those drug treatments. ‘A meticulous virtual copy of the human brain would enable basic research on brain cells and circuits or computer-based drug trials,’ explains Prof. Markram.
However, it’s not just medicine that will benefit – this computerised model of the brain will revolutionise information technology, allowing experts to design computers, robots and other devices far more powerful and intelligent than any we know today.
Researchers want to build neuromorphic, or brain-like, computers which would have processors that can learn, mimicking our brains. In other words, they want to throw new light on questions we humans have been asking since the dawn of times: what does it mean to perceive, to think, to remember and to learn?
Starting with the genes
However, the HBP is ambitious. The brain contains nearly 100 billion neurons organised into networks with 100 trillion total connections, all firing split-second spikes of voltage in a broth of complex biological molecules in constant flux.
Henry Markram is the Human Brain Project coordinator and leads the HBP Brain Simulation Division. © EPFL The HBP team will start by using supercomputers to investigate, even from the molecular level, how and which genes intervene in the process of information transferring in the neurons. The team will start working very soon on developing a detailed computer simulation.
As the model becomes more accurate and behaves more like a brain, the team will couple it to a robot and watch it ‘learn’. They’ll then be able to trace the chain of events from molecules to cognition.
Whisper it quietly, but the Human Brain Project really does have the potential to revolutionise technology, medicine and neuroscience.
‘The biggest success for me would be if, after 10 years, we have a new model for neuroscience where everyone works together,’ remarks Prof. Markram. ‘It’s about a new foundation.’
From rubber dandelions and toxic crustaceans to anti-vaxxers and the world’s hottest geothermal well, Horizon covered a wide variety of stories in 2017. Here are our 10 favourite science facts that we learned along the way.
Scientists in the Middle East are putting politics aside and using the region’s new particle accelerator, SESAME, to collaborate on experiments such as distinguishing between benign and malignant cancer tissues, and analysing historical parchments from religious texts, according to Dr Gihan Kamel, the infrared beamline scientist at the facility. She will be speaking at a session on science diplomacy at the World Science Forum in Jordan on 10 November with Carlos Moedas, the European Commissioner for Research, Science and Innovation.
The rise of alternative health practices and a quest for purity can partly explain the falling confidence in vaccines which is driving outbreaks of preventable diseases such as measles, according to Heidi Larson, professor of anthropology, risk and decision medicine at the UK’s London School of Hygiene & Tropical Medicine. She is working to understand the causes of vaccine hesitancy in order to devise ways of rebuilding trust.
Some materials are special not for what they contain, but for what they don’t contain. Such is the case with metal-organic frameworks (MOFs) – ultra-porous structures that are being developed for a variety of future applications from fire-proofing to drug-delivery.
Understanding people’s fears is the key to increasing confidence.
Are metal organic frameworks the hole-y grail of nanomaterials?
A new report on how to reinvigorate Europe's industrial sector recommends prioritising AI and cyber security research.